Data / Drug companies / Lonza AG
Lonza AG: 49 products in the FDA NDC directory, labeler code 49187
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lonza AG (labeler code 49187) lists 49 products in the FDA National Drug Code Directory. By type: 33 bulk ingredients, 16 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on March 24, 2026.
The request: Watch Lonza AG (FDA labeler code 49187): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 49187
- Products in commercial distribution
- 49
- Packages
- 61
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- July 31, 2003
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 67.3% |
| Drugs for further processing | 16 | 32.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 33 | 67.3% |
| Drugs for further processing | 16 | 32.7% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 33 | 67.3% |
| Liquid | 9 | 18.4% |
| Solution | 7 | 14.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tividenofusp alfa-eknm | 49187-5002 | Solution | Drugs for further processing | March 24, 2026 |
| Zibotentan (micronized) | 49187-0847 | Powder | Bulk ingredients | February 21, 2026 |
| Osimertinib mesylate | 49187-0846 | Powder | Bulk ingredients | February 20, 2026 |
| Sacituzumab govitecan | 49187-5001 | Liquid | Drugs for further processing | December 1, 2025 |
| Esafoxolaner | 49187-0845 | Powder | Bulk ingredients | June 30, 2025 |
| Momelotinib | 49187-0844 | Powder | Bulk ingredients | January 31, 2025 |
| Mogamulizumab | 49187-5000 | Liquid | Drugs for further processing | December 18, 2024 |
| Repotrectinib | 49187-0843 | Powder | Bulk ingredients | November 15, 2023 |
| Abemaciclib | 49187-0838 | Powder | Bulk ingredients | October 1, 2023 |
| Lenalidomide | 49187-0751 | Powder | Bulk ingredients | August 11, 2023 |
| Lenalidomide | 49187-0750 | Powder | Bulk ingredients | August 11, 2023 |
| Lonapegsomatropin-tcgd | 49187-0203 | Solution | Drugs for further processing | July 13, 2023 |
| Mpeg-7-oms 2,5,8,11,14,17,20-heptaoxadocosan-22-yl methanesulfonate | 49187-0839 | Liquid | Bulk ingredients | March 28, 2023 |
| Avacopan | 49187-0834 | Powder | Bulk ingredients | February 28, 2023 |
| Trastuzumab/deruxtecan | 49187-0224 | Liquid | Drugs for further processing | October 3, 2022 |
| Tisotumab vedotin | 49187-0207 | Liquid | Drugs for further processing | September 20, 2021 |
| Vandetanib non-mc | 49187-0221 | Powder | Bulk ingredients | February 1, 2021 |
| Voclosporin | 49187-0803 | Powder | Bulk ingredients | January 22, 2021 |
| Mecasermin | 49187-0810 | Solution | Drugs for further processing | April 23, 2020 |
| Enfortumab vedotin | 49187-0214 | Liquid | Drugs for further processing | December 31, 2019 |
| Rada (deaminase, adenosine) | 49187-0785 | Solution | Drugs for further processing | December 20, 2019 |
| Polatuzumab vedotin | 49187-0216 | Liquid | Drugs for further processing | November 29, 2019 |
| Brolucizumab | 49187-0226 | Solution | Drugs for further processing | October 31, 2019 |
| Ticagrelor | 49187-0205 | Powder | Bulk ingredients | September 5, 2019 |
| Bemelanotide | 49187-0759 | Powder | Bulk ingredients | July 31, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.